Effect of Maraviroc on Endothelial Function in HIV-Infected Patients.
Phase of Trial: Phase III
Latest Information Update: 13 Aug 2014
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- 23 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jan 2014 According to the ClinicalTrials.gov record planned end date changed from 1 Dec 2013 to 1 Jun 2014.
- 16 May 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.